Cayman
Cayman is a leader in the field of new psychoactive substances high-purity reference standards.
Cayman has more than 30 years of experience in the synthesis, purification, and characterisation of biochemicals. Its product range includes synthetic cannabinoids, cathinones, phenethylamines, amphetamines, opioids, benzodiazepines, tryptamines, and phytocannabinoids, among many others.
In addition to parent compounds, Cayman offers metabolites, isomers, deuterated and 13C-labeled standards, multi-standard mixtures, and compound libraries. For institutions that rely on highly traceable reference standards, Cayman offers reference materials and certified reference materials tested under an ISO/IEC 17025:2017 and ISO 17034:2016 accredited quality system.
Cayman Accreditations
Please see individual products for specific accreditation status See our accreditations